Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

Journal of Clinical Microbiology

Volumn 44, Issue 3, 2006, Pages 999-1017

  Beall, Bernard ^a,f   McEllistrem, M Catherine ^b   Gertz Jr , Robert E ^a   Wedel, Stephanie ^c   Boxrud, David J ^c   Gonzalez, Antonio L ^a   Medina, Marie Jo ^a   Pai, Rekha ^a   Thompson, Terry A ^a   Harrison, Lee H ^b,d   McGee, Lesley ^a,e   Whitney, Cynthia G ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c MINNESOTA DEPARTMENT OF HEALTH   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e EMORY UNIVERSITY   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CHLORAMPHENICOL DERIVATIVE; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; TETRACYCLINE DERIVATIVE;

ARTICLE; BACTERIAL MUTATION; BACTERIUM ISOLATION; CHEMICAL COMPOSITION; GENOTYPE; HUMAN; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINATION; VACCINE PRODUCTION;

ADULT; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; UNITED STATES;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

EID: 33644917475     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.3.999-1017.2006     Document Type: Article

References (33)

1. Active Bacterial Core Surveillance. 26 December 2004, posting date, http: //www.cdc.gov/ncidod/dbmd/abcs/.
2. Beall, B., M. C. McEllistrem, R. E. Gertz, D. J. Boxrud, J. M. Besser, L. H. Harrison, J. H. Jorgensen, C. G. Whitney, and the Active Bacterial Core Surveillance/Emerging Infections Program Network. 2002. Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States. J. Infect. Dis. 186:118-122.
3. Brueggemann, A. B., D. T. Griffiths, E. Meats, T. Peto, D. W. Crook, and B. G. Spratt. 2003. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 187:1424-1432.
4. Brueggemann, A. B., and B. G. Spratt. 2003. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J. Clin. Microbiol. 41:4966-4970.
5. Brueggemann, A. B., T. E. Peto, D. W. Crook, J. C. Butler, K. G. Kristinsson, and B. G. Spratt. 2004. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190:1203-1211.
6. Dagan, R., N. Givon-Lavi, O. Zamir, M. Sikuler-Cohen, L. Guy, J. Janco, P. Yagupsky, and D. Fraser. 2002. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J. Infect. Dis. 185:927-936.
7. Enright, M., and B. G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
8. Enright, M. C., and B. G. Spratt. 1999. Extensive variation in the ddl gene of penicillin-resistant Streptococcus pneumoniae results from a hitchhiking effect driven by the penicillin-binding protein 2b gene. Mol. Biol. Evol. 16:1687-1695.
9. Eskola, J., T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, E. Herva, A. Takala, H. Kayhty, P. Karma, R. Kohberger, G. Siber, and P. H. Makelä. 2001. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344:403-409.
10. Farrell, D. J., S. G. Jenkins, S. D. Brown, M. Patel, B. S. Lavin, and K. P. Klugman. 2005. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg. Infect. Dis. 11:851-858.
11. Feil, E. J., B. C. Li, D. M. Aanensen, W. P. Hanage, and B. G. Spratt. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530.
12. Gertz, R. E., M. C. McEllistrem, D. J. Boxrud, Z. Li, V. Sakota, T. A. Thompson, R. R. Facklam, J. M. Besser, L. H. Harrison, C. G. Whitney, and B. Beall. 2003. Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J. Clin. Microbiol. 41:4194-4216.
13. Ghaffar, F., T. Barton, J. Lozano, L. S. Muniz, P. Hicks, V. Gan, N. Ahmad, and G. H. McCracken, Jr. 2004. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin. Infect. Dis. 39:930-938.
14. Gherardi, G., C. G. Whitney, R. R. Facklam, and B. Beall. 2000. Major sets of genetically related β-lactam resistant pneumococci in the United States based upon PFGE and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J. Infect. Dis. 181:216-229.
15. Johanna, M., C. Jefferies, A. Smith, S. C. Clarke, C. Dowson, and T. J. Mitchell. 2004. Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching. J. Clin. Microbiol. 42:5681-5688.
16. Kaplan, S. L., E. O. Mason, Jr., E. R. Wald, G. E. Schutze, J. S. Bradley, T. Q. Tan, J. A. Hoffman, L. B. Givner, R. Yogev, and W. J. Barson. 2004. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113:443-449.
17. Konradsen, H. B. 2005. Validation of serotyping of Streptococcus pneumoniae in Europe. Vaccine 23:1368-1373.
18. Leimkugel, J., A. Adams Forger, S. Gagneux, V. Pfluger, C. Flierl, E. Awine, M. Naegeli, J. P. Dangy, T. Smith, A. Hodgson, and G. Pluschke. 2005. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J. Infect. Dis. 192:192-199.
19. McEllistrem, M. C., J. Adams, E. O. Mason, and E. R. Wald. 2003. Epidemiology of acute otitis media caused by Streptococcus pneumomae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J. Infect. Dis. 188:1679-1684.
20. Meats, E., A. B. Brueggemann, M. C. Enright, K. Sleeman, D. T. Griffiths, D. W. Crook, and B. G. Spratt. 2003. Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J. Clin. Microbiol. 41:386-392.
21. Medina, M. J., C. M. Greene, R. E. Gertz, R. R. Facklam, G. Jagero, M. Hamel, Y. P. Shi, L. Slutsker, D. R. Feikin, and B. Beall. 2005. Novel antibiotic-resistant pneumococcal strains recovered from the upper respiratory tracts of HIV-infected adults and their children in Kisumu, Kenya. Microb. Drug Resist. 11:9-17.
22. Mizrachi Nebenzahl, Y., N. Porat, S. Lifzitch, S. Novick, A. Levi, E. Ling, O. Liron, S. Mordechai, R. K. Sahu, and R. Dagan. 2004. Virulence of Streptococcus pneumoniae may be determined independently of the capsular polysaccharide. FEMS Microbiol. Lett. 233:147-152.
23. Pai, R., M. R. Moore, T. Pilishvili, R. E. Gertz, C. G. Whitney, and B. Beall. 2005. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192:1988-1995.
24. Pai, R., R. E. Gertz, C. G. Whitney, and B. Beall. 2005. Clonal association between Streptococcus pneumoniae serotype 23A, circulating within the United States, and an internationally dispersed clone of serotype 23F. J. Clin. Microbiol. 43:5440-5444.
25. Pantosti, A., G. Gherardi, M. Conte, F. Faella, G. Dicuonzo, and B. Beall. 2002. A novel, multiple drug-resistant, serotype 24F strain of Streptococcus pneumoniae that caused meningitis in patients in Naples, Italy. Clin. Infect. Dis. 35:205-208.
26. Pletz, M. W., L. McGee, J. Jorgensen, B. Beall, R. R. Facklam, C. G. Whitney, and K. P. Klugman. 2004. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob. Agents Chemother. 48:3491-3497.
27. Pneumococcal Molecular Epidemiology Network. 20 December 2004, posting date. http://www.sph.emory.edu/PMEN/index.html.
28. Pneumococcal Multilocus Sequence Typing. 20 December 2004, posting date, http://spneumoniae.mlst.net/#.
29. Porat, N., A. Arguedas, B. G. Spratt, R. Trefler, E. Brilla, C. Loaiza, D. Godoy, N. Bilek, and R. Dagan. 2004. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J. Infect. Dis. 190:2154-2161.
30. Sandgren, A., K. Sjostrom, B. Olsson-Liljequist, B. Christensson, A. Samuelsson, G. Kronvall, and B. Henriques Normark. 2004. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J. Infect. Dis. 189:785-796.
31. Schutze, G. E., N. C. Tucker, and E. O. Mason, Jr. 2004. Impact of the conjugate pneumococcal vaccine in Arkansas. Pediatr. Infect. Dis. J. 23:1125-1129.
32. van Selm, S., L. M. van Cann, M. A. Kolkman, B. A. van der Zeijst, and J. P. van Putten. 2003. Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides. Infect. Immun. 71:6192-6198.
33. Whitney, C. G., M. M. Farley, J. Hadler, L. H. Harrison, N. M. Bennett, R. Lynfield, A. Reingold, P. R. Cieslak, T. Pilishvili, D. Jackson, R. R. Facklam, J. H. Jorgensen, and A. Schuchat. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746.